Using Scientific Validation to Move the Needle on Accessibility Functionalities Webinar Replay
Part 2 of the Clario Oncology Webinar Series
With the advance of technology, new opportunities to improve clinical trial experience from a site and patient perspective come into existence. As regulatory bodies are demanding use of accessibility functionality to improve inclusivity, Clario’s scientific team is currently assessing the level of scientific research required to validate the use of the accessibility features such as zoom in/zoom out and ensure data integrity is maintained.
In Part 2 of the Clario Oncology Webinar Series replay, the presenters will discuss the accessibility features and present results to date on this industry first study and provide an insight into the next steps for accessibility functionalities.
What you’ll learn:
- All eCOA equivalence studies that have been carried out in the last 20 years before have paved the way for accessibility functionality testing.
- Accessibility features require science to assess if there could be a potential impact on data integrity.
- Although initial research has been completed, there is further work to be done to make accessibility a reality for would-be trial participants.
